EUROFINS SCIENTIFIC SE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.64 EUR | -1.50% |
|
-4.84% | -3.97% |
| Apr. 24 | CAC40: interest rates soar, pulling back below 8100 pts | CF |
| Apr. 24 | EUROFINS SCIENTIFIC : Q1 sees a lacklustre start to the year; 2024 outlook confirmed |  |
| Sales 2024 * | 7.06B 7.54B | Sales 2025 * | 7.6B 8.12B | Capitalization | 10.92B 11.68B |
|---|---|---|---|---|---|
| Net income 2024 * | 397M 424M | Net income 2025 * | 557M 596M | EV / Sales 2024 * | 2 x |
| Net Debt 2024 * | 3.22B 3.44B | Net Debt 2025 * | 3.19B 3.41B | EV / Sales 2025 * | 1.86 x |
| P/E ratio 2024 * |
27.6
x | P/E ratio 2025 * |
20.3
x | Employees | 61,798 |
| Yield 2024 * |
1.01% | Yield 2025 * |
1.38% | Free-Float | 66.78% |
More Fundamentals
* Assessed data
More news
Latest transcript on Eurofins Scientific SE
More recommendations
More press releases
More news
| 1 day | -1.50% | ||
| 1 week | -4.84% | ||
| Current month | -4.13% | ||
| 1 month | -0.39% | ||
| 3 months | -0.74% | ||
| 6 months | +23.83% | ||
| Current year | -3.97% |
1 week
55.70
61.96
1 month
55.7062.10
Current year
51.3262.10
1 year
44.8365.24
3 years
44.83127.68
5 years
34.56127.68
10 years
16.30127.68
| Managers | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 61 | 86-12-31 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 14-12-31 |
Christian Wurst
COO | Chief Operating Officer | - | 19-09-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 61 | 86-12-31 |
Yves-Loïc Martin
BRD | Director/Board Member | 58 | 91-12-31 |
Valérie Hanote
BRD | Director/Board Member | 58 | 90-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.47% | 18 M€ | +3.79% | - | |
| 0.40% | 5 M€ | +4.56% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 56.64 | -1.50% | 413,821 |
| 24-04-25 | 57.5 | +1.16% | 640,360 |
| 24-04-24 | 56.84 | -7.73% | 660,784 |
| 24-04-23 | 61.6 | +2.19% | 294,191 |
| 24-04-22 | 60.28 | +1.28% | 278,154 |
Real-time Euronext Paris, April 26, 2024 at 11:35 am EDT
More quotes
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products.
At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world.
Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).
Calendar
2024-07-24
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
56.64
EUR
Average target price
60.88
EUR
Spread / Average Target
+7.48%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -3.97% | 11.66B | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -1.42% | 11.72B | |
| -31.75% | 11.77B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- ERF Stock
